| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2007 | WO2006112744A3 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 02/22/2007 | WO2006110555A9 Cleansing foaming sunscreen lotion |
| 02/22/2007 | WO2006108695A3 Sulfoximine-pyrimidine macrocycles and the salts thereof , a process for making them, and their pharmaceutical use against cancer |
| 02/22/2007 | WO2006108681A3 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria |
| 02/22/2007 | WO2006108679A3 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer |
| 02/22/2007 | WO2006107948A9 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
| 02/22/2007 | WO2006105214A3 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 02/22/2007 | WO2006103261A3 Inhibitors of neurotrypsin and determination thereof |
| 02/22/2007 | WO2006102439A3 Treatment or prevention of cancer and precancerous disorders |
| 02/22/2007 | WO2006102285A3 Method for the protection of trees |
| 02/22/2007 | WO2006099351A3 Hydrocodone polymorphs |
| 02/22/2007 | WO2006098998A9 Methods and compositions for modulating vascular integrity |
| 02/22/2007 | WO2006098834A3 Crystalline forms of ziprasidone mesylate |
| 02/22/2007 | WO2006097617B1 Novel dihydropyrimidine derivatives and their use as anti-cancer agents |
| 02/22/2007 | WO2006097263A3 Orally used compatible solute containing agents |
| 02/22/2007 | WO2006096398A3 Medicaments |
| 02/22/2007 | WO2006093547A3 Novel lipoxygenase inhibitors |
| 02/22/2007 | WO2006091898A3 Pyrazolyl substituted xanthines |
| 02/22/2007 | WO2006091897A3 Derivatives of 8-substituted xanthines |
| 02/22/2007 | WO2006091896A3 Pyridyl substituted xanthines |
| 02/22/2007 | WO2006091703A3 Multimediator 5-ht6 receptor antagonists, and uses related thereto |
| 02/22/2007 | WO2006091395A3 Inhibitors of akt activity |
| 02/22/2007 | WO2006086706B1 A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
| 02/22/2007 | WO2006086667A3 Antisense composition and method for treating muscle atrophy |
| 02/22/2007 | WO2006081431A3 Compounds for treating inflammatory and demyelinating diseases |
| 02/22/2007 | WO2006078941A3 Novel sirtuin activating compounds and methods of use thereof |
| 02/22/2007 | WO2006076370B1 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 02/22/2007 | WO2006076015A3 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof |
| 02/22/2007 | WO2006073448A3 Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| 02/22/2007 | WO2006068978A3 Dipeptidyl peptidase inhibitors |
| 02/22/2007 | WO2006066244A3 Method for extending lifespan and delaying the onset of age-related disease |
| 02/22/2007 | WO2006065842A3 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof |
| 02/22/2007 | WO2006062981A3 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 02/22/2007 | WO2006061525A3 Compositions for treating surface ocular pathologies |
| 02/22/2007 | WO2006060823A3 Apoptosis-specific eif-5a and polynucleotides encoding same |
| 02/22/2007 | WO2006059169A3 Antiviral and immunostimulating marine fish oil composition |
| 02/22/2007 | WO2006052798B1 Method of treating pathological blushing |
| 02/22/2007 | WO2006050351A3 Compounds and compositions as hedgehog pathway modulators |
| 02/22/2007 | WO2006047673A3 Mammalian genes involved in infection |
| 02/22/2007 | WO2006042102A3 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 02/22/2007 | WO2006039488A3 Hcv ns3-ns4a protease inhibition |
| 02/22/2007 | WO2006036278A3 THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF |
| 02/22/2007 | WO2006033709A8 Novel nucleoside derivatives |
| 02/22/2007 | WO2006032959A3 Processes for the preparation of pyrrole derivatives |
| 02/22/2007 | WO2006028967A3 Regulation of oncogenes by micrornas |
| 02/22/2007 | WO2006022611A3 Neuropathy cream |
| 02/22/2007 | WO2006019841A3 Treatment of viral infections with egr 1 activators |
| 02/22/2007 | WO2006014549A8 Synthesis of azo bonded immunoregulatory compounds |
| 02/22/2007 | WO2006010152A8 Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones |
| 02/22/2007 | WO2006002185A8 Chemical compounds |
| 02/22/2007 | WO2006002119A3 Kinase inhibitors for treating cancers |
| 02/22/2007 | WO2005123077A8 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof |
| 02/22/2007 | WO2005120582A3 Compositions and methods for inhibiting expression of hypoxia-inducible genes |
| 02/22/2007 | WO2005120516A3 Hiv integrase inhibitors |
| 02/22/2007 | WO2005105113A3 Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine |
| 02/22/2007 | WO2005094376A3 Synergistic methods and compositions for treating cancer |
| 02/22/2007 | WO2005047300A3 Improved methods and compositions for rna interference |
| 02/22/2007 | WO2005042719A3 Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents |
| 02/22/2007 | WO2005042718A3 Compositions and methods for treating, preventing, reversing and inhibiting pain |
| 02/22/2007 | WO2005011616A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | WO2003073991A3 Methods to increase or decrease bone density |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension |
| 02/22/2007 | US20070043214 Derivatives of azithromycin |
| 02/22/2007 | US20070043206 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/22/2007 | US20070043122 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
| 02/22/2007 | US20070043121 Discovery of novel soluble crystalline anesthetics |
| 02/22/2007 | US20070043120 Therapeutic combination for painful medical conditions |
| 02/22/2007 | US20070043119 Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/22/2007 | US20070043118 Method of treating a subject suffering from degenerative disc disease using a nitric oxide synthase inhibitor |
| 02/22/2007 | US20070043117 preparation of chirally pure nateglinide by treating a lower alkyl ester thereof with a base to yield an alkali salt and liberating the product from said salt by proper addition of an acid |
| 02/22/2007 | US20070043116 Method for preventing and/or treating neurodegenerative diseases |
| 02/22/2007 | US20070043115 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 02/22/2007 | US20070043114 Nerve regeneration promoters |
| 02/22/2007 | US20070043113 Novel compounds |
| 02/22/2007 | US20070043112 Use of non-opiates for the potentation of opiates |
| 02/22/2007 | US20070043111 Use of ifenprodril in the treatment of pain |
| 02/22/2007 | US20070043110 Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins |
| 02/22/2007 | US20070043109 Slimming cosmetic composition |
| 02/22/2007 | US20070043108 Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| 02/22/2007 | US20070043107 subjecting 4-acyl-4-alkoxycarbonyltetrahydropyran to decarboxylation in the presence of a mineral acid (sulfuric acid or hydrochloric acid) in a solvent e.g.ethanol |
| 02/22/2007 | US20070043106 Alpha-lipoic acid concentrate |
| 02/22/2007 | US20070043105 Preventive for cerebal stroke recurrence |
| 02/22/2007 | US20070043104 UII-modulating compounds and their use |
| 02/22/2007 | US20070043103 Novel metod for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 02/22/2007 | US20070043102 Oral suspension of tegaserod |
| 02/22/2007 | US20070043101 [4-({5-[(1,1'-biphenyl-4-ylsulfonyl)amino]-1H-indol-1-yl}methyl)phenoxy]acetic acid; inhibiting PAI-1 activity; treat impairment of the fibrinolytic system; thrombosis; cardiovascular disease; chronic obstructive pulmonary disease, renal fibrosis, polycystic ovary syndrome, Alzheimer's disease, cancer |
| 02/22/2007 | US20070043100 Novel polymorphs of azabicyclohexane |
| 02/22/2007 | US20070043099 Crystalline forms of carvedilol and processes for their preparation |
| 02/22/2007 | US20070043098 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 02/22/2007 | US20070043097 Medicaments containing famotidine and ibuprofen and administration of same |
| 02/22/2007 | US20070043096 Unit dose form with ibuprofen-famotidine admixture |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043094 Pioglitazone hydrochloride |
| 02/22/2007 | US20070043093 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 02/22/2007 | US20070043092 Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders |
| 02/22/2007 | US20070043091 Kv1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY |
| 02/22/2007 | US20070043090 Novel Sulfonamides |
| 02/22/2007 | US20070043089 Method of inhibiting angiogenesis |